Palvella Therapeutics, Inc.
PVLA
$23.44
-$1.13-4.60%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 488.46% | -2.27% | 97.78% | 0.00% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 420.63% | 43.65% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 234.60% | -- | -- | -- |
| Total Current Assets | 440.62% | 6.37% | -- | -- | -- |
|
|
|||||
| Total Current Assets | 440.62% | 6.37% | -- | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 440.62% | 6.37% | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | 46.52% | 116.46% | -- | -- | -- |
| Total Accrued Expenses | 1.47% | 55.37% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1,023.05% | 22.08% | -- | -- | -- |
| Total Other Current Liabilities | 1,023.05% | 22.08% | -- | -- | -- |
| Total Current Liabilities | 57.67% | 73.72% | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | 57.67% | 73.72% | -- | -- | -- |
| Long-Term Debt | -50.38% | 21.37% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 16.15% | 5.58% | -- | -- | -- |
| Total Liabilities | -22.63% | 29.54% | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | 6,468.87% | 9.12% | -- | -- | -- |
| Retained Earnings | -4.40% | -8.16% | -- | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 171.63% | -8.14% | -8.52% | 0.00% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 0.00% | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | -- |
|
|
|||||
| Total Common Equity | 171.63% | -8.14% | -8.52% | 0.00% | -- |
| Total Preferred Equity | -- | 0.00% | 0.00% | 0.00% | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 472.64% | -64.31% | -163.53% | 0.00% | -- |
|
|
|||||